InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Egan Dwight H, Chairman & CEO. Director active across 2 companies, notably Co-Diagnostics, Inc.. Cumulatively, 13 reports have been published. History available since 24 May 2021. The latest transaction was filed on 23 May 2026 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Egan Dwight H
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
1,633 shares@ US$5.070.15% mcap100.0% of flowCommon StockSEC:0001712187-26-000002:1
4,584 shares0Common StockSEC:0001712187-26-000002:0
163,333 shares0Common StockSEC:0001712187-25-000002:0
163,334 shares0Common StockSEC:0001562180-25-004200:0
51,697 shares@ US$0.2460.7% of flowCommon StockSEC:0001562180-25-004200:1
163,333 shares0Common StockSEC:0001562180-24-007928:0
138,333 shares0Common StockSEC:0001562180-24-004436:0
150,834 shares0Common StockSEC:0001562180-23-007921:0
105,000 shares0Common StockSEC:0001562180-23-004444:0
79,166 shares0Common StockSEC:0001562180-22-007852:0
33,334 shares0Common StockSEC:0001562180-22-004379:0
33,333 shares0Common StockSEC:0001562180-21-007256:0
12,500 shares0Common StockSEC:0001562180-21-003741:0
13 of 13 declarations
About Egan Dwight H
Egan Dwight H is Président-Directeur Général and Chief Executive Officer of Co-Diagnostics, Inc. Across 13 filings, the sampled recent filings cover the period from 2021-05-26 to 2026-05-27, with 18122 euros of sales and 0 euro of purchases, and the modal transaction nature is Attribution.
